289 related articles for article (PubMed ID: 34517190)
1. High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics.
Lui A; Chong J; Flanagan E; Abrams AW; Krysko KM; Arikan B; Francisco C; Rutatangwa A; Waubant E; Ziaei A
Mult Scler Relat Disord; 2021 Nov; 56():103253. PubMed ID: 34517190
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.
Jarius S; Lechner C; Wendel EM; Baumann M; Breu M; Schimmel M; Karenfort M; Marina AD; Merkenschlager A; Thiels C; Blaschek A; Salandin M; Leiz S; Leypoldt F; Pschibul A; Hackenberg A; Hahn A; Syrbe S; Strautmanis J; Häusler M; Krieg P; Eisenkölbl A; Stoffels J; Eckenweiler M; Ayzenberg I; Haas J; Höftberger R; Kleiter I; Korporal-Kuhnke M; Ringelstein M; Ruprecht K; Siebert N; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; Rostásy K;
J Neuroinflammation; 2020 Sep; 17(1):262. PubMed ID: 32883358
[TBL] [Abstract][Full Text] [Related]
3. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
[TBL] [Abstract][Full Text] [Related]
4. Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.
Waters P; Fadda G; Woodhall M; O'Mahony J; Brown RA; Castro DA; Longoni G; Irani SR; Sun B; Yeh EA; Marrie RA; Arnold DL; Banwell B; Bar-Or A;
JAMA Neurol; 2020 Jan; 77(1):82-93. PubMed ID: 31545352
[TBL] [Abstract][Full Text] [Related]
5. Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability.
Kwon YN; Kim B; Kim JS; Mo H; Choi K; Oh SI; Kim JE; Nam TS; Sohn EH; Heo SH; Kim SB; Park KC; Yoon SS; Oh J; Baek SH; Kim BJ; Park KS; Sung JJ; Jung JH; Kim SJ; Park SH; Waters P; Kim SM
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34711644
[TBL] [Abstract][Full Text] [Related]
6. Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination.
Zhou J; Lu X; Zhang Y; Ji T; Jin Y; Xu M; Bao X; Zhang Y; Xiong H; Chang X; Jiang Y; Wu Y
Mult Scler Relat Disord; 2019 Feb; 28():4-10. PubMed ID: 30529926
[TBL] [Abstract][Full Text] [Related]
7. Clinical and MRI phenotype of children with MOG antibodies.
Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
[TBL] [Abstract][Full Text] [Related]
8. Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes.
Zhou Y; Jia X; Yang H; Chen C; Sun X; Peng L; Kermode AG; Qiu W
Eur J Neurol; 2019 Jan; 26(1):175-183. PubMed ID: 30153357
[TBL] [Abstract][Full Text] [Related]
9. Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing.
Sechi E; Buciuc M; Pittock SJ; Chen JJ; Fryer JP; Jenkins SM; Budhram A; Weinshenker BG; Lopez-Chiriboga AS; Tillema JM; McKeon A; Mills JR; Tobin WO; Flanagan EP
JAMA Neurol; 2021 Jun; 78(6):741-746. PubMed ID: 33900394
[TBL] [Abstract][Full Text] [Related]
10. Clinical risk factors for recurrence of myelin oligodendrocyte glycoprotein antibody-associated disease.
Wang J; Yang K; Zhang F; Yi Y; Wang J
Mult Scler Relat Disord; 2023 Sep; 77():104879. PubMed ID: 37442076
[TBL] [Abstract][Full Text] [Related]
11. Patterns and utility of myelin oligodendrocyte glycoprotein (MOG) antibody testing in cerebrospinal fluid.
Burton JM; Youn S; Al-Ani A; Costello F
J Neurol; 2024 May; 271(5):2662-2671. PubMed ID: 38366070
[TBL] [Abstract][Full Text] [Related]
12. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
13. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
Jarius S; Pellkofer H; Siebert N; Korporal-Kuhnke M; Hümmert MW; Ringelstein M; Rommer PS; Ayzenberg I; Ruprecht K; Klotz L; Asgari N; Zrzavy T; Höftberger R; Tobia R; Buttmann M; Fechner K; Schanda K; Weber M; Asseyer S; Haas J; Lechner C; Kleiter I; Aktas O; Trebst C; Rostasy K; Reindl M; Kümpfel T; Paul F; Wildemann B;
J Neuroinflammation; 2020 Sep; 17(1):261. PubMed ID: 32883348
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.
Tea F; Lopez JA; Ramanathan S; Merheb V; Lee FXZ; Zou A; Pilli D; Patrick E; van der Walt A; Monif M; Tantsis EM; Yiu EM; Vucic S; Henderson APD; Fok A; Fraser CL; Lechner-Scott J; Reddel SW; Broadley S; Barnett MH; Brown DA; Lunemann JD; Dale RC; Brilot F;
Acta Neuropathol Commun; 2019 Sep; 7(1):145. PubMed ID: 31481127
[TBL] [Abstract][Full Text] [Related]
16. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.
Duignan S; Wright S; Rossor T; Cazabon J; Gilmour K; Ciccarelli O; Wassmer E; Lim M; Hemingway C; Hacohen Y
Dev Med Child Neurol; 2018 Sep; 60(9):958-962. PubMed ID: 29468668
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of low versus high titers of MOG-IgG and their clinical implications in myelin oligodendrocyte glycoprotein antibody-associated disease: a retrospective singlecenter study].
Li Z; Wang D; Chen J; Huang X; Wu Y; Hu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1865-1873. PubMed ID: 38081603
[TBL] [Abstract][Full Text] [Related]
18. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
Jitprapaikulsan J; Chen JJ; Flanagan EP; Tobin WO; Fryer JP; Weinshenker BG; McKeon A; Lennon VA; Leavitt JA; Tillema JM; Lucchinetti C; Keegan BM; Kantarci O; Khanna C; Jenkins SM; Spears GM; Sagan J; Pittock SJ
Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
[TBL] [Abstract][Full Text] [Related]
19. Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome.
Wendel EM; Thonke HS; Bertolini A; Baumann M; Blaschek A; Merkenschlager A; Karenfort M; Kornek B; Lechner C; Pohl D; Pritsch M; Schanda K; Schimmel M; Thiels C; Waltz S; Wiegand G; Anlar B; Barisic N; Blank C; Breu M; Broser P; Della Marina A; Diepold K; Eckenweiler M; Eisenkölbl A; Freilinger M; Gruber-Sedlmayr U; Hackenberg A; Iff T; Knierim E; Koch J; Kutschke G; Leiz S; Lischetzki G; Nosadini M; Pschibul A; Reiter-Fink E; Rohrbach D; Salandin M; Sartori S; Schlump JU; Stoffels J; Strautmanis J; Tibussek D; Tüngler V; Utzig N; Reindl M; Rostásy K;
Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36229191
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System Demyelination.
Ayroza Galvão Ribeiro Gomes AB; Kulsvehagen L; Lipps P; Cagol A; Cerdá-Fuertes N; Neziraj T; Flammer J; Lerner J; Lecourt AC; de Oliveira S Siebenborn N; Cortese R; Schaedelin S; Andreoli Schoeps V; de Moura Brasil Matos A; Trombini Mendes N; Dos Reis Pereira C; Ribeiro Monteiro ML; Dos Apóstolos-Pereira SL; Schindler P; Chien C; Schwake C; Schneider R; Pakeerathan T; Aktas O; Fischer U; Mehling M; Derfuss T; Kappos L; Ayzenberg I; Ringelstein M; Paul F; Callegaro D; Kuhle J; Papadopoulou A; Granziera C; Pröbstel AK
JAMA Neurol; 2023 Sep; 80(9):989-995. PubMed ID: 37548987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]